Picture of boy being examining by doctor at a tuberculosis sanatorium

Understanding our future through Open Access research about our past...

Strathprints makes available scholarly Open Access content by researchers in the Centre for the Social History of Health & Healthcare (CSHHH), based within the School of Humanities, and considered Scotland's leading centre for the history of health and medicine.

Research at CSHHH explores the modern world since 1800 in locations as diverse as the UK, Asia, Africa, North America, and Europe. Areas of specialism include contraception and sexuality; family health and medical services; occupational health and medicine; disability; the history of psychiatry; conflict and warfare; and, drugs, pharmaceuticals and intoxicants.

Explore the Open Access research of the Centre for the Social History of Health and Healthcare. Or explore all of Strathclyde's Open Access research...

Image: Heart of England NHS Foundation Trust. Wellcome Collection - CC-BY.

Biofluids and other techniques : general discussion

Goodacre, Royston and Baker, Matthew J. and Graham, Duncan and Schultz, Zachary D. and Diem, Max and Marques, Maria Paula and Cinque, Gianfelice and Vernooij, Robbin and Sulé-Suso, Josep and Byrne, Hugh J. and Faulds, Karen and Hermes, Michael and Fleming, Holly and Bonifacio, Alois and Dluhy, Richard and Gardner, Peter and El-Mashtoly, Samir and Wood, Bayden and Gough, Kathleen and Fornasaro, Stefano and Kazarian, Sergei and Jamieson, Lauren and Petrich, Wolfgang and Sockalingum, Ganesh Dhruvananda and Stone, Nick and Kendall, Catherine and Sinjab, Faris and Haris, Parvez and Subaihi, Abdu and Remiszewski, Stan and Hellwig, Petra and Sergo, Valter and Gerwert, Klaus and Phillips, Christopher and Campbell, Colin J. (2016) Biofluids and other techniques : general discussion. Faraday Discussions, 187. pp. 575-601. ISSN 1359-6640

Full text not available in this repository. Request a copy from the Strathclyde author


Richard Dluhy opened a general discussion of the paper by Duncan Graham: In your example of a heterogeneous solution-based assay for multicomponent analysis, what is the concentration of the target fungal ssPCR DNA that is used, and how do you manage the kinetics of the reaction such that the target reaches the probe in a time frame appropriate for a clinical assay?